1-Jose Biller, Betsy B. Love, and Michael J. Schneck. In:Bradley's Neurology in Clinical Practice. 5th ed. Philadelphia: Butterworth-Heinemann/Elsevier; 2008
2-Hacke W, Kaste M, Bluhmki E,
Brozman M,
Dávalos A,
Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New Eng J Med 2008;359(13):1317-29.
3-Sacco RL. chapter 41. In: Rowland LP, editor. 11th ed. Merritt's neurology. Philadelphia: Lippincott Williams & Wilkins, 2005.
4-Kidwell CH, Menon R, Burgess R. Albumin for intracerebral hemorrhage intervention (ACHIEVE). Available at: URL: http://www. clinical trials.gov; identifires.gov; identifier number : NCT00990509
5-Norrving, B. Cerebral hemorrhage. In: Ginsberg M, Bogousslavsky J, eds. Cerebrovascular disease: pathophysiology, diagnosis, and management. Malden: Blackwell Science; 1998
6-Fogelholm R, Nuutila M, Vuorela AL. Primary intracerebral haemorrhage in the Jyväskylä region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry 1992;55(7):546–52
7-Belayev L, Alonso OF, Huh PW, Zhao W, Busto R, Ginsberg MD. Posttreatmentwith high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J Neurotrauma 1999;16(6):445–53.
8-Giroud M, Gras P, Chadan N,
Beuriat P,
Milan C,
Arveux P, et al. Cerebral haemorrhage in a French prospective population study. J Neurol Neurosurg Psychiatry 1991;54(7):595-8.
9-Thrift AG, McNeil JJ, Forbes A, Donnan GA. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 1998;31(6):1223-9.
10-Belayev L, Pinard E, Nallet H,
Seylaz J,
Liu Y,
Riyamongkol P, et al. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke 2002;33(4):1077–84.
11-Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A. Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr 2007;61(11):1318-22.
13-
Belayev L,
Liu Y,
Zhao W,
Busto R,
Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001;32(2):553- 60.
14-Suarez JI, Shannon L,
Zaidat OO,
Suri MF,
Singh G,
Lynch G, et al. Effect of human albumin administration on clinical outcome and hospital lost in paitents with subarachnoid hemorrhage.
J Neurosurg. 2004;100(4):585-90.
15-Belayev L, Saul I,
Busto R,
Danielyan K,
Vigdorchik A,
Khoutorova L, et al. Albumin treatment reduces neurological deficit and protect blood brain barrier integrity after acute intracortical hematoma in the rat.
Stroke 2005;36(2):326-31.